Dual-Target Herbicidal Inhibitors of Lysine Biosynthesis

Technology
In development
University
Scouted & summarized by Halo AI

MBDTA-2 is a novel dual-target herbicidal inhibitor that disrupts plant lysine biosynthesis by targeting two essential enzymes, DHDPS and DHDPR. This innovative approach provides a breakthrough solution for managing herbicide-resistant weeds. By focusing on a biosynthetic pathway unique to plants, it offers a selective, high-potential alternative to traditional agricultural herbicides currently facing declining efficacy.

Overview

MBDTA-2 is a novel, dual-target herbicidal inhibitor that disrupts the lysine biosynthesis pathway in plants. By targeting two essential enzymes—dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate reductase (DHDPR)—this inhibitor offers a promising strategy for managing herbicide-resistant weeds. Because humans and animals do not synthesize lysine and must acquire it through diet, targeting this pathway is highly selective, providing an effective mode of action for next-generation agricultural crop protection.

Technical specifications

The inhibitor features a unique mechanism of action:

  • Dual-Target Inhibition: It inhibits the rate-limiting enzyme DHDPS at a novel allosteric site and binds to the active site of the subsequent enzyme, DHDPR.
  • Proven Efficacy: Demonstrates pre-emergence herbicidal activity and growth attenuation in model plants like Arabidopsis thaliana and problematic agricultural weeds such as rigid ryegrass (Lolium rigidum).
  • High Selectivity: Designed to target conserved plant enzymes while minimizing impact on non-target organisms, addressing the global need for alternatives to conventional herbicides.
  • Structural Insights: Validated through biochemical enzyme kinetic assays, static docking, and structural biology techniques.
Technology readiness level

The technology is currently at TRL 4. Researchers have successfully validated the dual-target mechanism in laboratory settings, demonstrated in vitro enzyme inhibition, and conducted preliminary in planta proof-of-concept studies using model organisms and specific weeds. The technology is supported by international patent filings.

Generated Jul 7, 2026. Please verify key information.

About La Trobe University

La Trobe University is a comprehensive public research university based in Melbourne, serving metropolitan and regional Australia through a multi‑campus footprint. Its Research and Innovation Precinct at the Bundoora campus enables industry co‑location, shared facilities, and streamlined access to talent. Collaborations with state agencies and Melbourne’s hospital network, plus a digital innovation hub and accelerator programs, provide pathways for prototyping, validation, and co‑development. Research is supported by competitive national funding, including the Australian Research Council and National Health and Medical Research Council, alongside industry partnerships and Cooperative Research Centre programs. A dedicated technology transfer office manages IP, licensing, and startup formation.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.